CRISPR Therapeutics AG (CRSP) Fell -5.17% or -1.95 To Price $35.75 On Monday


CRISPR Therapeutics AG (CRSP) fell -5.17% or -1.95 to $35.75. It is close to 482481 shares traded, which is 39.33% compare to the average total volume 1.23 million. The market cap of CRSP is $1.69 billion. The year to date change is 44.61%. The 52 week price range is from $16.51 to $73.9. Price of CRSP have changed 3.12% during last week. It have changed -29.83% over last month, -42.04% over last 3 months, -28.27% over last 6 months and 101.39% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRSP is 47.38. It is 32.53% above current price. The 200-day Moving Averages for CRSP is 49.25. It is 37.76% above current price. The 52-week High is 73.9. It is 106.71% from the current price. The 52-week Low is 16.51. It is -53.82% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRSP is 3.61 on 2018-09-28. Short % to float is 8.49%. There are some statistics of CRSP. It is has market cap $1.69 billion. The share outstanding is 47.33 million. The average volume is 1.23 million. The revenue is 2.39M. The percent of top 15 Institution holding is 62.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRSP is -39.04%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRSP is -27.44%.


Tags:

Share this post